RA
TMDX icon

Royce & Associates’s Transmedics TMDX Stock Holding History

Royce & Associates’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-244,382
Closed -$24.3M – 830
2026
Q1 		$24.3M Buy
244,382
+1,233
+0.5% +$161K 0.24% 110
2025
Q4 		$29.6M Hold
243,149
– – 0.3% 89
2025
Q3 		$27.3M Sell
243,149
-4,252
-2% -$498K 0.27% 109
2025
Q2 		$33.2M Sell
247,401
-49,799
-17% -$5.47M 0.34% 76
2025
Q1 		$20M Buy
297,200
+2
+0% +$138 0.22% 137
2024
Q4 		$18.5M Hold
297,198
– – 0.17% 168
2024
Q3 		$46.7M Sell
297,198
-4,000
-1% -$616K 0.42% 51
2024
Q2 		$45.4M Sell
301,198
-14,000
-4% -$1.68M 0.42% 49
2024
Q1 		$23.3M Sell
315,198
-36,500
-10% -$3.01M 0.21% 133
2023
Q4 		$27.8M Buy
351,698
+210,000
+148% +$12.7M 0.26% 108
2023
Q3 		$7.76M Buy
141,698
+4,198
+3% +$302K 0.08% 359
2023
Q2 		$11.5M Sell
137,500
-22,000
-14% -$1.68M 0.11% 271
2023
Q1 		$12.1M Sell
159,500
-32,500
-17% -$2.25M 0.12% 241
2022
Q4 		$11.9M Buy
192,000
+40,000
+26% +$2.13M 0.12% 251
2022
Q3 		$6.34M Buy
152,000
+10,000
+7% +$435K 0.07% 394
2022
Q2 		$4.47M Buy
142,000
+55,000
+63% +$1.47M 0.05% 502
2022
Q1 		$2.34M Buy
87,000
+26,000
+43% +$466K 0.02% 692
2021
Q4 		$1.17M Buy
+61,000
New +$1.53M 0.01% 784
2020
Q4 		– Sell
-41,000
Closed -$565K – 1040
2020
Q3 		$565K Buy
+41,000
New +$702K 0.01% 848

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Royce & Associates's TMDX Position: Q2 2026 in Review

Royce & Associates sold out of Transmedics (TMDX) in Q2 2026, closing a stake of 244,382 shares — an estimated $24.3M sold.

Royce & Associates first reported a position in TMDX in Q3 2020 and held it in 19 quarters. The position peaked at $46.7M in Q3 2024. 374 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Royce & Associates reported no remaining Transmedics position as of Q2 2026 after selling out during the quarter.
  • Royce & Associates sold 244,382 Transmedics shares in Q2 2026, an estimated $24.3M.
  • Royce & Associates first reported a position in Transmedics in Q3 2020 and held it in 19 quarters.
  • Royce & Associates's Transmedics position peaked at $46.7M in Q3 2024.
  • 374 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Royce & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.